Tan C.-H.SUNG-CHUN TANGLin R.-J.JIANN-SHING JENG2021-12-222021-12-222010223050https://www.scopus.com/inward/record.uri?eid=2-s2.0-77958134584&doi=10.1136%2fjnnp.2009.194878&partnerID=40&md5=e596e4e7bd63739e38bf8439d726db5ahttps://scholars.lib.ntu.edu.tw/handle/123456789/590538[SDGs]SDG3alteplase; angiotensin 2 receptor antagonist; atenolol; complement component C3; complement component C4; diphenhydramine; hydrocortisone; indapamide; irbesartan; propafenone; angiotensin 1 receptor antagonist; biphenyl derivative; fibrinolytic agent; tetrazole derivative; tissue plasminogen activator; aged; anamnesis; angioneurotic edema; aphasia; article; blood cell count; case report; cerebral artery disease; computer assisted tomography; female; hemiparesis; homonymous hemianopia; human; National Institutes of Health Stroke Scale; orolingual angioedema; priority journal; tongue hypesthesia; angioneurotic edema; chemically induced disorder; mouth disease; stroke; Aged, 80 and over; Angioedema; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Female; Fibrinolytic Agents; Humans; Mouth Diseases; Stroke; Tetrazoles; Tissue Plasminogen Activatorjournal article10.1136/jnnp.2009.194878205476192-s2.0-77958134584